Parenteral iron therapy exacerbates experimental sepsis Rapid Communication
- 1 June 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 65 (6) , 2108-2112
- https://doi.org/10.1111/j.1523-1755.2004.00742.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Parenteral iron therapy exacerbates experimental sepsis Rapid CommunicationKidney International, 2004
- Oxidative stress and renal injury with intravenous iron in patients with chronic kidney diseaseKidney International, 2004
- Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporterKidney International, 2003
- Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in HumansCirculation, 2002
- Glutathione Protects Mice from Lethal Sepsis by Limiting Inflammation and Potentiating Host DefenseThe Journal of Infectious Diseases, 2002
- Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysisKidney International, 2001
- Vitamin E, lipid profile, and peroxidation in hemodialysis patientsKidney International, 2001
- Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1Kidney International, 2001
- Higher levels of antioxidant defenses in enalapril-treated versus non–enalapril-treated hemodialysis patientsAmerican Journal of Kidney Diseases, 1999
- C-reactive protein as an outcome predictor for maintenance hemodialysis patientsKidney International, 1998